These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20013309)

  • 1. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.
    Kaushik P; Singh DK; Kumar SV; Tiwari AK; Shukla G; Dayal S; Chaudhuri P
    Vet Res Commun; 2010 Feb; 34(2):119-32. PubMed ID: 20013309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice.
    Lim JJ; Kim DH; Lee JJ; Kim DG; Min W; Lee HJ; Rhee MH; Kim S
    J Vet Sci; 2012 Sep; 13(3):287-92. PubMed ID: 23000585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brucella antigens (BhuA, 7α-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    J Immunol Methods; 2022 Jan; 500():113172. PubMed ID: 34673003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
    Tabynov K; Yespembetov B; Ryskeldinova S; Zinina N; Kydyrbayev Z; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Vaccine; 2016 Jan; 34(4):438-444. PubMed ID: 26709638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice.
    Truong QL; Cho Y; Park S; Park BK; Hahn TW
    Microb Pathog; 2016 Jun; 95():175-185. PubMed ID: 27057678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.
    He Y; Vemulapalli R; Schurig GG
    Infect Immun; 2002 May; 70(5):2535-43. PubMed ID: 11953393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of recombinant 28 kDa outer membrane protein of Brucella abortus for the clinical diagnosis of bovine brucellosis in Korea.
    Lim JJ; Kim DH; Lee JJ; Kim DG; Min W; Lee HJ; Rhee MH; Chang HH; Kim S
    J Vet Med Sci; 2012 Jun; 74(6):687-91. PubMed ID: 22214857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.
    Dabral N; Martha-Moreno-Lafont ; Sriranganathan N; Vemulapalli R
    PLoS One; 2014; 9(9):e107180. PubMed ID: 25225910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
    Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S
    Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.
    Al-Mariri A; Tibor A; Lestrate P; Mertens P; De Bolle X; Letesson JJ
    Infect Immun; 2002 Apr; 70(4):1915-23. PubMed ID: 11895955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A
    Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
    Tadepalli G; Konduru B; Murali HS; Batra HV
    Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.